Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms
Description
Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient. MeSH
Hierarchy View
Subtype Terms (39)
Aging, Premature
1 approved drug
Asthenia
1 approved drug
Body Temperature Changes
6 drugs (5 approved, 1 experimental)
Body Weight
69 drugs (30 approved, 39 experimental)
Cardiac Output, Low
18 drugs (11 approved, 7 experimental)
Chills
1 approved drug
Cyanosis
2 drugs (1 approved, 1 experimental)
Edema
71 drugs (51 approved, 20 experimental)
Eye Manifestations
1 approved drug
Failure to Thrive
2 approved drugs
Fatigue
130 drugs (80 approved, 50 experimental)
Fetal Distress
6 drugs (4 approved, 2 experimental)
Hot Flashes
67 drugs (33 approved, 34 experimental)
Hyperlactatemia
10 approved drugs
Hypertriglyceridemic Waist
1 approved drug
Intermittent Claudication
52 drugs (25 approved, 27 experimental)
Medically Unexplained Symptoms
Mobility Limitation
11 drugs (9 approved, 2 experimental)
Motion Sickness
10 drugs (6 approved, 4 experimental)
Myocardial Stunning
11 drugs (9 approved, 2 experimental)
Neurologic Manifestations
14 drugs (10 approved, 4 experimental)
Oral Manifestations
4 drugs (2 approved, 2 experimental)
Prodromal Symptoms
1 approved drug
Pseudophakia
7 approved drugs
Renal Colic
33 drugs (23 approved, 10 experimental)
Signs and Symptoms, Digestive
14 drugs (6 approved, 8 experimental)
Signs and Symptoms, Respiratory
8 drugs (7 approved, 1 experimental)
Skin Manifestations
11 drugs (8 approved, 3 experimental)
Sleepiness
2 approved drugs
Travel-Related Illness
1 experimental drug
Urological Manifestations
40 drugs (24 approved, 16 experimental)
Phase 4 Indicated Drugs (17)
Phase 3 Indicated Drugs (6)
Phase 1 Indicated Drugs (6)
Other Experimental Indicated Drugs (12)
Organization Involved with Phase 4 Indications (24)
Organization Involved with Phase 3 Indications (19)
Organization Involved with Phase 2 Indications (18)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (19)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
